M&G plc’s Insmed INSM Stock Holding History

M&G plc’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.42M	Sell	88,008 -10,213	-10%	-$1.24M	0.05%	223
2026 Q1	$16.1M	Buy	+98,221	New	+$15.1M	0.08%	146

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

M&G plc's INSM Position: Q2 2026 in Review

M&G plc reduced its Insmed (INSM) stake by 10% in Q2 2026, selling an estimated $1.24M and leaving 88,008 shares worth $9.42M. The position accounts for 0.05% of the portfolio, ranked #223.

M&G plc first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.1M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

M&G plc held 88,008 shares of Insmed worth $9.42M as of Q2 2026.
M&G plc sold 10,213 Insmed shares in Q2 2026, an estimated $1.24M.
Insmed made up 0.05% of M&G plc's portfolio in Q2 2026, its #223 holding.
M&G plc first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
M&G plc's Insmed position peaked at $16.1M in Q1 2026.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.